Home › Research › Health systems and care delivery
Examining Barriers and Strategies to Improve Alzheimer's Disease Care in the Veterans Affairs Setting
Arushi Kapoor, Jeffrey Carter, Emma Landau, Chris Napolitan, Laura Simone, Larissa A. Jarzylo, Andrew E. Budson. Alzheimer s & Dementia, 2025-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
A total of 144 surveys were collected from VA clinicians at baseline and during audit-feedback sessions (Table). Difficulty diagnosing AD and time constraints related to discussion of treatment options were the greatest challenges in managing AD among identified by providers. Clinicians identified patient hesitancy in discussing symptoms of dementia and challenges in distinguishing between normal aging from dementia symptoms as top factors which contributed to delayed diagnosis of AD. In patients diagnosed with early AD, difficulties with care coordination and patients' mental (eg cognitive impairment) or social issues (eg behavioral changes) were the main reasons eligible patients did not receive DMTs. Clinical pathway or formulary restrictions and lack of time to align treatment paradigms with emerging evidence were identified as additional challenges to administering DMTs to eligible patients. Following the sessions, process changes included implementation of a cognitive testing workflow, improvements to documentation of screening and assessment in the EMR, education for clinicians to support shared treatment decision-making with patients, and formation of a dementia care working group. These findings highlight barriers in early diagnosis and management of AD in the VA setting. Action plans designed to address these barriers have resulted in implementation of process improvements.
What this study adds
Evidence grade: Low
The record lists 144 participants. This survey of VA clinicians identified barriers to diagnosing Alzheimer's disease and to delivering disease-modifying treatments, and led to process changes such as a cognitive testing workflow. It does not test a treatment, cure, or prevention for Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kapoor, A., Carter, J., Landau, E., Napolitan, C., Simone, L., Jarzylo, L. A., et al. (2025). Examining Barriers and Strategies to Improve Alzheimer's Disease Care in the Veterans Affairs Setting. Alzheimer s & Dementia. https://doi.org/10.1002/alz70858_102944
Vancouver
Kapoor A, Carter J, Landau E, Napolitan C, Simone L, Jarzylo LA, et al. Examining Barriers and Strategies to Improve Alzheimer's Disease Care in the Veterans Affairs Setting. Alzheimer s & Dementia. 2025. doi:10.1002/alz70858_102944. PMID: 41445135.
BibTeX
@article{kapoor2025-41445135,
author = {Kapoor, Arushi and Carter, Jeffrey and Landau, Emma and Napolitan, Chris and Simone, Laura and Jarzylo, Larissa A. and Budson, Andrew E.},
title = {{Examining Barriers and Strategies to Improve Alzheimer's Disease Care in the Veterans Affairs Setting}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70858_102944},
pmid = {41445135},
url = {https://doi.org/10.1002/alz70858_102944}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- A total of 144 surveys were collected from VA clinicians at baseline and during audit-feedback sessions (Table).
- Difficulty diagnosing AD and time constraints related to discussion of treatment options were the greatest challenges in managing AD among identified by providers.
- Clinicians identified patient hesitancy in discussing symptoms of dementia and challenges in distinguishing between normal aging from dementia symptoms as top factors which contributed to delayed diagnosis of AD.
- In patients diagnosed with early AD, difficulties with care coordination and patients' mental (eg cognitive impairment) or social issues (eg behavioral changes) were the main reasons eligible patients did not receive DMTs.
- Clinical pathway or formulary restrictions and lack of time to align treatment paradigms with emerging evidence were identified as additional challenges to administering DMTs to eligible patients.
Why it matters
This survey of VA clinicians identified barriers to diagnosing Alzheimer's disease and to delivering disease-modifying treatments, and led to process changes such as a cognitive testing workflow. It does not test a treatment, cure, or prevention for Alzheimer's disease.
Study details
- Participants144
- Evidence strengthLow
How this study scored 37/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 144 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Andrew E. Budson: h-index 72 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Boston University: institution h-index 1,456 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41445135) |
| Free to read | 2 / 2 | Free to read |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70858_102944
- PubMed: 41445135
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Health systems and care delivery from nearby years
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.